Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-read sequencing for cancer liquid biopsy: advancing precision oncology.

Frontiers in oncology·2026
Same author

Endoscopic transsphenoidal resection of large sellar chondrosarcoma compressing the optic nerve: illustrative case.

Journal of neurosurgery. Case lessons·2026
Same author

Impact of baseline brain metastases on survival and CNS progression in NSCLC patients treated with immune checkpoint inhibitors in real-world studies: a systematic review and meta-analysis.

Translational lung cancer research·2026
Same author

Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation.

Life science alliance·2026
Same author

Contributing Factors to Delay of Adjuvant Postsurgical Radiation for Malignant Brain Tumors: A Single Institution Experience in a Rural State.

American journal of clinical oncology·2025
Same author

Survival Outcomes of Immune Checkpoint Inhibitors in Conjunction with Cranial Radiation for Older Adults with Non-Small Cell Lung Cancer and Synchronous Brain Metastasis.

Current oncology (Toronto, Ont.)·2025
Same journal

Explainable incremental-value analysis of apparent diffusion coefficient and arterial spin labeling radiomics for ATRX status prediction in glioblastoma.

Frontiers in oncology·2026
Same journal

Study-level factors associated with hematoma after ultrasound-guided vacuum-assisted breast lesion excision: a systematic review and meta-analysis using a T-P-B framework.

Frontiers in oncology·2026
Same journal

Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma.

Frontiers in oncology·2026
Same journal

Anastomosing hemangioma of the kidney: a case report.

Frontiers in oncology·2026
Same journal

Machine learning-based prediction of prolonged air leak after uniportal video-assisted thoracic surgery segmentectomy.

Frontiers in oncology·2026
Same journal

Past present and future of radiosensitization in cervical cancer.

Frontiers in oncology·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2025

Ultra-long Read Sequencing for Whole Genomic DNA Analysis
10:34

Ultra-long Read Sequencing for Whole Genomic DNA Analysis

Published on: March 15, 2019

22.8K

Long-read sequencing for brain tumors.

William J Shelton1, Sara Zandpazandi2, J Stephen Nix3

  • 1Department of Neurosurgery, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States.

Frontiers in Oncology
|June 25, 2024
PubMed
Summary
This summary is machine-generated.

Third-generation sequencing offers advanced brain tumor characterization by analyzing longer DNA segments for improved diagnosis and treatment. This technology enhances the detection of structural variants and epigenetics, aiding neuro-oncology patient care.

Keywords:
brain tumorsliquid biopsylong-read sequencingmolecular diagnosticsthird generation sequencing

More Related Videos

Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq
06:22

Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq

Published on: August 25, 2020

12.2K
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

18.2K

Related Experiment Videos

Last Updated: Jun 23, 2025

Ultra-long Read Sequencing for Whole Genomic DNA Analysis
10:34

Ultra-long Read Sequencing for Whole Genomic DNA Analysis

Published on: March 15, 2019

22.8K
Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq
06:22

Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq

Published on: August 25, 2020

12.2K
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

18.2K

Area of Science:

  • Neuro-oncology
  • Genomics
  • Molecular Biology

Background:

  • Brain tumor genomics has a significant history, with glioblastoma being the first cancer studied by The Cancer Genome Atlas.
  • Advances in sequencing technologies have enabled detailed molecular characterization for brain tumor diagnosis, prognosis, and treatment.
  • Molecular biomarkers have been integrated into diagnostic criteria by the WHO CNS since 2016.

Purpose of the Study:

  • To provide a comprehensive summary of the current state of third-generation sequencing for brain tumor applications.
  • To discuss the advantages and potential clinical implementations of long-read sequencing in neuro-oncology.

Main Methods:

  • Review of current literature on third-generation sequencing (long-read sequencing) in the context of brain tumors.
  • Analysis of the capabilities of long-read sequencing for detecting structural variants and epigenetics.

Main Results:

  • Third-generation sequencing allows for the analysis of longer DNA segments compared to traditional methods.
  • This enhanced capability leads to improved detection of crucial genomic alterations in brain tumors.
  • The technology holds promise for more precise characterization of brain tumors.

Conclusions:

  • Long-read sequencing represents a significant advancement in brain tumor molecular characterization.
  • Its application in diagnosis, prognosis, and treatment offers potential improvements for neuro-oncology patients.
  • Further integration into clinical paradigms is anticipated to enhance patient care.